Status: Not yet recruiting
Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP).
This study is testing a new investigational study drug called Urcosimod Ophthalmic Solution for the treatment of Neuropathic Corneal Pain (NCP).
Participants needed: 111
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Okyo Pharma LtdUpdated: Sep 29, 2026Locations: 1
Eligibility criteria
Aged 18 years of age or older. [+9]
Evidence of any active ocular infection (bacterial, viral, fungal or protozoal)... [+20]